The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
GENETRON HLDGS LTD | ADS | 37186H100 | 252 | 322,082 | SH | SOLE | 322,082 | 0 | 0 | ||
LUCKIN COFFEE INC | SPONSORED ADS | 54951L109 | 3,795 | 230,000 | SH | SOLE | 230,000 | 0 | 0 | ||
RLX TECHNOLOGY INC | SPONSORED ADS | 74969N103 | 2,100 | 2,000,000 | SH | SOLE | 2,000,000 | 0 | 0 | ||
YATSEN HLDG LTD | ADS | 985194109 | 4,927 | 4,520,000 | SH | SOLE | 4,520,000 | 0 | 0 | ||
VANECK VECTORS ETF TR | GOLD MINERS ETF | 92189F106 | 9,648 | 400,000 | SH | SOLE | 400,000 | 0 | 0 | ||
CHROMADEX CORP | COM NEW | 171077407 | 2,378 | 1,933,041 | SH | SOLE | 1,933,041 | 0 | 0 | ||
QUDIAN INC | ADR | 747798106 | 6,845 | 7,605,000 | SH | SOLE | 7,605,000 | 0 | 0 | ||
SORRENTO THERAPEUTICS INC | COM NEW | 83587F202 | 1,244 | 792,037 | SH | SOLE | 792,037 | 0 | 0 |